This research not only elucidates a pyroptotic pathway associated with metabolites but also unveils a previously unreported central pathway extending from ROS-triggered DR6 endocytosis to caspase-8-mediated cleavage of GSDMC, suggesting potential clinical applications in tumor therapy. This evidence concerns the gene CASP8 and neoplasm.